FiercePharma

European Commission approves Cialis® (tadalafil) tablets for the treatment of the signs and symptoms of benign prostatic hyperplasia

Cialis becomes only medication approved in the EU for both erectile dysfunction and signs and symptoms of benign prostatic hyperplasia INDIANAPOLIS, Oct. 30, 2012 /PRNewswire/ -- Eli Lilly and Company ...
FiercePharma

Cialis® for Once Daily Use Now FDA-Approved to Treat Men With Signs and Symptoms of Benign Prostatic Hyperplasia (BPH) and Men W

INDIANAPOLIS, Oct. 7, 2011 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) has approved Cialis® (tadalafil) tablets for once daily ...
FierceBiotech

FDA Approves Addition to CIALIS® (tadalafil) Product Label

Study Data Shows Cialis 5 mg Initiated with Finasteride Provides Significantly Greater Improvements in Urinary Symptoms of Benign Prostatic Hyperplasia than Placebo with Finasteride INDIANAPOLIS, Oct.
Monthly Prescribing Reference

Once-daily Cialis approved

The FDA has approved Cialis (tadalafil, from Eli Lilly) for once-daily use in the treatment of erectile dysfunction (ED). The once-daily dosing option uses a low-dose regimen that may be more ...